scholarly journals The potential impact of COVID 19 on poor and conflict-ridden communities in Sub-Sahara Africa (SSA): A conceptual paper

2020 ◽  
Vol 1 (2) ◽  
pp. 125-132
Author(s):  
Mathew Nyashanu ◽  
Tistsi Tsopotsa ◽  
Scovia Nalugo Mbalinda ◽  
Gemma North ◽  
Maureen Mguni ◽  
...  
Keyword(s):  
Policy Development ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Public Health Professionals ◽  
Global Pandemic ◽  
Potential Impact ◽  
Wu Zhao ◽  
Future Policy ◽  
Novel Coronavirus

The first cases of the novel coronavirus disease (COVID-19), previously known as 2019-nCoV, were reported in late December 2019 in Wuhan, China (Wu, Zhao, Yu B, et al 2020). The virus then spread to Malaysia and Thailand and eventually to the Americas, Europe, Australia and Africa. On the 11thof March 2020 the World Health Organisation (WHO) declared the COVID-19 a global pandemic. This concept paper  explores the potential impact of COVID-19 on poverty stricken and conflict-ridden communities in Sub-Sahara Africa. In doing so, the paper also explored the implications for public health professionals working with these communities, including recommendation for future policy development.

scholarly journals A cross-sectional study for determining the perception and preferences of immunity boosters for protection against COVID-19

2020 ◽  
Vol 7 (10) ◽  
pp. 1498
Author(s):  
Dhairya P. Nanavaty ◽  
Ankushi A. Sanghvi ◽  
Manav S. Mehta ◽  
Sarbari Gupta ◽  
Gurusharan Dumra
Keyword(s):  
Family Doctor ◽  
Drug Market ◽  
World Health Organisation ◽  
Cross Sectional Study ◽  
World Health ◽  
The Novel ◽  
Cross Sectional ◽  
Global Pandemic ◽  
Novel Coronavirus ◽  
Source Of Information

Background: The World Health Organisation declared the novel coronavirus (COVID-19) outbreak as a global pandemic on March 11, 2020.  The consumption of vitamins, especially C, D, and zinc, hydroxychloroquine, and Arsenicum album 30 (homeopathy), has increased tremendously. However, the clinical trial showing the benefits of these agents is still underway though there have been a lot of discussion about these in print, electronic, and social media.Method: A questionnaire-based observational study was conducted. The participants were inquired about the use of any type of immunity booster by them and the source of information regarding the same. The data was analysed using Excel and Python.Results: Our study included 1147 participants. A dramatic increase of 21.97% in the consumption of immunity-boosting agents after the COVID-19 outbreak was observed, maximally in Ayurveda. The major source of information for immunity-boosters was provided by friends/family/relatives (50.4%). 52.7% of the respondents selected Ayurveda as their preferred choice of immunity booster (prophylaxis). If the respondents were to develop any of the COVID-19 symptoms, the majority (45.1%) decided to contact their family doctor, and 53.7% chose Allopathy as their preferred system for treatment. 91.5% of the respondents agreed to take a vaccine if it develops.Conclusion: There has been a boom in the immunity booster drug market because people are selecting immunity boosters despite no scientific background. It is imperative to educate people regarding the same and also conduct research studies to find benefits, if any.

scholarly journals Pneumomediastinum in a child with severe COVID-19

2020 ◽  
pp. 20200062
Author(s):  
Anne G Carroll ◽  
Nuala Quinn ◽  
Carl Byrne ◽  
Ghadir Kassab ◽  
Siobhan Whelan ◽  
...  
Keyword(s):  
Health Care Providers ◽  
Clinical Course ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Care Providers ◽  
Radiological Findings ◽  
Global Pandemic ◽  
International Data ◽  
Novel Coronavirus

The current global pandemic of the novel coronavirus SARS-CoV2 is a threat to the health and lives of millions of people worldwide. The latest statistics from the World Health Organisation show that there have been 6,515,796 confirmed cases worldwide with 387,298 confirmed deaths (last update 5 June 2020, 10:41 CEST). The majority of critically unwell patients with SARS-CoV2 are adults and the radiological findings associated with them are consistent throughout the literature. However, the reported paediatric cases are few, and as such, there is a limited body of evidence available. More international data is needed, not only on the clinical presentation, but also the radiological findings, so that health-care providers are better able to understand and diagnose this pandemic disease. We describe a case of a previously healthy 9-year-old female who presented to the Emergency Department with symptoms suggestive of raised intracranial pressure. Her CT revealed a medulloblastoma and post-operatively she tested positive for SARS-CoV2. She had a rapid deterioration in her clinical condition and required admission to the intensive care unit (ICU). We provide the supporting radiology along her clinical course in order to demonstrate important insights into this disease in children, including the unusual pnemomediastinum complications which occurred as part of her clinical course. This case is the first reported of its kind.

Jordan’s Public Health and Surveillance Health Policies: During and After COVID-19 (Preprint)

2020 ◽  
Author(s):  
Raeda AlQutob ◽  
Musa Taha Ajlouni ◽  
Mohamed Majed Abu Farraj ◽  
Immanuel Azaad Moonesar
Keyword(s):  
Public Health ◽  
Health System ◽  
Health Financing ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Future Health ◽  
Health Crisis ◽  
Global Pandemic ◽  
Novel Coronavirus

UNSTRUCTURED In contemporary times, the wave of the novel Coronavirus disease (COVID-19) classified by the World Health Organisation as global pandemic has unravelled systems and processes including health, economic and social. In the case of the Kingdom of Jordan, the COVID-19 crisis illustrated for the need and ability of the policy making institutions and ministries to take many effective policies, initiatives and procedures that were met with marked approval as the opinion polls conducted by government and private institutions showed. The success of these interventions during the crisis calls upon the country’s health system to take advantage of this experience in the next stage of recovery and resilience to develop, maintain its sustainability, as well as the improvement of a number of hubs to assist the Kingdom in facing the challenges resulting from any future health crisis such as epidemics or natural disasters. The viewpoint interventions that are the most paramount given the current situation as public health evidence must inform activities in seven priority health system areas to manage during and after the pandemic includes factors on: (1) governance and management; (2) service delivery and research; (3) human resources; (4) health information systems; (5) technology and medicine; (6) health financing; and (7) citizens, refugees and communities.

Comparative docking of SARS-CoV-2 receptors antagonists from repurposing drugs

2020 ◽  
Author(s):  
Micael Davi Lima de Oliveira ◽  
Kelson Mota Teixeira de Oliveira
Keyword(s):  
World Health Organisation ◽  
World Health ◽  
Lung Cells ◽  
The Novel ◽  
High Modulation ◽  
Main Protease ◽  
The World ◽  
Novel Coronavirus ◽  
Viral Receptors ◽  
Theoretical Results

According to the World Health Organisation, until 16 June, 2020, the number of confirmed and notified cases of COVID-19 has already exceeded 7.9 million with approximately 434 thousand deaths worldwide. This research aimed to find repurposing antagonists, that may inhibit the activity of the main protease (Mpro) of the SARS-CoV-2 virus, as well as partially modulate the ACE2 receptors largely found in lung cells, and reduce viral replication by inhibiting Nsp12 RNA polymerase. Docking molecular simulations were performed among a total of 60 structures, most of all, published in the literature against the novel coronavirus. The theoretical results indicated that, in comparative terms, paritaprevir, ivermectin, ledipasvir, and simeprevir, are among the most theoretical promising drugs in remission of symptoms from the disease. Furthermore, also corroborate indinavir to the high modulation in viral receptors. The second group of promising drugs includes remdesivir and azithromycin. The repurposing drugs HCQ and chloroquine were not effective in comparative terms to other drugs, as monotherapies, against SARS-CoV-2 infection.

scholarly journals Therapeutic approaches to tackle COVID-19: An overview

2021 ◽  
Vol 8 (2) ◽  
pp. 121-135
Author(s):  
Princy Louis Palatty ◽  
Rosme David ◽  
Belinda Mangalath Philip ◽  
Clint Sunny ◽  
Mamatha J ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Treatment Guidelines ◽  
World Health Organisation ◽  
Current Medical ◽  
World Health ◽  
Director General ◽  
The Novel ◽  
Therapeutic Approaches ◽  
Literature Searches ◽  
Novel Coronavirus

: A series of an acute atypical respiratory disease occurred during December 2019 in Wuhan, China, that quickly metamorphosed as a pandemic, spreading across the globe, leaving more than 104,911,186 infected and more than 2,278,579 dead, in its wake within a year. This Novel Coronavirus, was also called Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and the disease was called Coronavirus Disease 19 (COVID-19). On 30 January 2020, The World Health Organisation (WHO) Director-General, declared the novel coronavirus outbreak, a public health emergency of international concern and flagged off WHO's highest level of alarm.: To elaborate the various drug therapies used in trials and vaccines available for COVID-19 across the globe.: We compiled the literature searches under a single heading and scrutinized over 154 articles, for extracting data on the various pharmacotherapeutic approaches available to treat COVID-19.: Despite wide and varied treatment guidelines being available, the cure or prevention is still elusive for COVID-19. The categoric efficacy of vaccines must be proved to tackle the fast-mutating coronavirus.: Current medical management is largely supportive with no targeted therapy available. Several drugs including lopinavir-ritonavir, remdesivir, antibiotics, hydroxychloroquine, steroids, anticoagulants, and antidiabetic drugs like metformin have been tried in clinical trials. Vaccines targeting the three different components of SARS-CoV-2 viruses, in different phases of clinical trials world-wide, have been made available.

scholarly journals The Information Infrastructure of Search Engines: A Content Analysis of Covid-19 Immunization Information Online

2021 ◽  
Vol 6 (2) ◽  
Author(s):  
Renée Belliveau
Keyword(s):  
Content Analysis ◽  
Search Engines ◽  
World Health ◽  
The Novel ◽  
Online Search ◽  
Global Pandemic ◽  
The World ◽  
Global Spread ◽  
Novel Coronavirus ◽  
Health Organization

After the World Health Organization declared the spread of the novel coronavirus (COVID-19) a global pandemic in March 2020, they cautioned of another outbreak: an “infodemic.” This study examines how online search engines are influencing the global spread of immunization information about COVID-19. It aims to address the various ways in which search technology is shaping users’ perceptions of the pandemic and to measure the credibility of the sources they provide.

scholarly journals Respiratory Viral Co-infection with Novel Coronavirus in Children: A Case Series

2020 ◽  
Author(s):  
Emily Hertzberg ◽  
C. Anthoney Lim ◽  
Erick Eiting ◽  
Steven Yung ◽  
Jeranil Nunez ◽  
...  
Keyword(s):  
Clinical Presentation ◽  
Case Series ◽  
Respiratory Viruses ◽  
World Health ◽  
Clinical Implications ◽  
The Novel ◽  
Global Pandemic ◽  
Surgical Evaluation ◽  
Novel Coronavirus ◽  
Health Organization

Abstract Background:The novel coronavirus, COVID-19 was identified in January 2020 initially in Wuhan, China but quickly spread worldwide and was declared a global pandemic by the World Health Organization on March 11, 2020. There are more than 185 countries impacted and the numbers of cases and deaths continues to rise. The rate of coinfections with COVID-19 in children and the clinical implications are unknown.Case Presentation:We describe the clinical presentation and course of three patients with COVID-19 and coinfections with other common respiratory viruses. Two cases were diagnosed with COVID-19 as well as rhinovirus/enterovirus and the third case was COVID-19 and pertussis. Each case had a unique presentations and hospital courses including an emergency room discharge, urgent surgical evaluation and an intensive care unit admission.Conclusions:This is the first US-based case report to discuss coinfections with COVID-19 and other respiratory viruses. Decisions regarding diagnosis and management of children in the setting of the current pandemic should account for the possibility of coinfections. We also highlight publish health challenged resulting from children with the novel coronavirus.

scholarly journals Novel COVID-19 Global Outbreak and a Need for Proactive Dental Care

2020 ◽  
Author(s):  
Prachi Gupta ◽  
Abhinav Garg ◽  
Lovejeet Ahuja
Keyword(s):  
Health Care Professionals ◽  
Preventive Measures ◽  
Dental Health ◽  
World Health Organisation ◽  
World Health ◽  
Cross Contamination ◽  
Dental Health Care ◽  
Global Pandemic ◽  
Screening Assessment ◽  
Novel Coronavirus

The global pandemic Novel Coronavirus Disease (COVID-19), which originated in Wuhan, has affected the countries worldwide and has been declared as a public health emergency by World Health Organisation. Because of the exclusive features of dental healthcare set-ups, risk of cross-contamination is greater between patients and dental personnel due to high chances of getting in contact with suspected or asymptomatic COVID-19 patients. Preventive measures are essential to be taken for prevention of furthermore spread of nosocomial infection. The present article provides a brief overview on COVID-19 in dental settings and recommended protocols for screening/assessment, patient management and precautions for dental health care professionals.

scholarly journals Year of the Mask; COVID-19 Challenges for Orthopaedic Surgery

2020 ◽  
Vol 10 ◽  
Author(s):  
Evert Smith
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Orthopaedic Surgery ◽  
World Health Organisation ◽  
World Health ◽  
The Novel ◽  
Virus Spread ◽  
Central Hospital ◽  
The World ◽  
Respiratory Physician ◽  
Novel Coronavirus

As a response to the viral pneumonias and severe illnesses that were emerging in patients, an ophthalmologist November 2019 a novel coronavirus emerged in Wuhan, Hubei, China Dr Li Wenliang, working at Wuhan Central Hospital, voiced his concerns only to be severely admonished by the authorities. The accelerated spread of the Severe Acute Respiratory Syndrome (SARS) in Wuhan, and then globally, as a result of the novel coronavirus was acute and pronounced. China alerted the World Health Organisation to several pneumonia cases at the end of December 2019 and the first death was recorded in early January 2020. The respiratory physician Dr Nanshan Zhong, announced human-to-human spread and a few days later on the 23 January 2020, Wuhan was placed under quarantine. The virus spread outside China and the WHO declared the outbreak a global health emergency on 30 January 2020. Tragically Dr Li Wenliang died on 7 February 2020 as a result of exposure to the virus, leaving a five-year-old son and a pregnant wife.

scholarly journals Community grid management is an important measure to contain the spread of novel coronavirus pneumonia (COVID-19)

2020 ◽  
Vol 148 ◽  
Author(s):  
Chen Ling ◽  
Xianjie Wen
Keyword(s):  
Control Measures ◽  
World Health ◽  
The Novel ◽  
Source Of Infection ◽  
Global Pandemic ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization ◽  
And Control ◽  
Grid Management

Abstract The outbreak of novel coronavirus pneumonia (coronavirus disease 2019 (COVID-19)), declared as a ‘global pandemic’ by the World Health Organization (WHO), is a public health emergency of international concern (PHEIC). The outbreak in multiple locations shows a trend of accelerating spread around the world. China has taken a series of powerful measures to contain the spread of the novel coronavirus. In response to the COVID-19 pandemic, in addition to actively finding effective treatment drugs and developing vaccines, it is more important to identify the source of infection at the community level as soon as possible to block the transmission path of the virus to prevent the spread of the pandemic. The implementation of grid management in the community and the adoption of precise management and control measures to reduce unnecessary personnel movement can effectively reduce the risk of pandemic spread. This paper mainly describes that the grid management mode can promote the refinement and comprehensiveness of community management. As a management system with potential to improve the governance ability of community affairs, it may be helpful to strengthen the prevention and control of the epidemic in the community.

Sign in / Sign up

Export Citation Format

Share Document